Exportar registro bibliográfico


Metrics:

A hybrid protein containing MSP1a repeats and Omp7, Omp8 and Omp9 epitopes protect immunized BALB/c mice against anaplasmosis (2018)

  • Authors:
  • USP affiliated authors: EPIPHANIO, SABRINA - FCF ; MARINHO, CLAUDIO ROMERO FARIAS - ICB
  • Unidades: FCF; ICB
  • DOI: 10.1186/s13567-018-0503-4
  • Subjects: VACINAS; ANAPLASMOSE ANIMAL; IMUNIZAÇÃO; PARASITOLOGIA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Online source accessDOI
    Informações sobre o DOI: 10.1186/s13567-018-0503-4 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: gold
    • Licença: cc-by

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CANGUSSU, Alex Sander Rodrigues; MARIÚBA, Luis André M; LALWANI, Pritesh; et al. A hybrid protein containing MSP1a repeats and Omp7, Omp8 and Omp9 epitopes protect immunized BALB/c mice against anaplasmosis. Veterinary Research, London, BioMed Central Ltd, v. 49, n. 1, p. 1-11 art. 6, 2018. Disponível em: < http://dx.doi.org/10.1186/s13567-018-0503-4 > DOI: 10.1186/s13567-018-0503-4.
    • APA

      Cangussu, A. S. R., Mariúba, L. A. M., Lalwani, P., Pereira, K. D. E. S., Astolphi-Filho, S., Orlandi, P. P., et al. (2018). A hybrid protein containing MSP1a repeats and Omp7, Omp8 and Omp9 epitopes protect immunized BALB/c mice against anaplasmosis. Veterinary Research, 49( 1), 1-11 art. 6. doi:10.1186/s13567-018-0503-4
    • NLM

      Cangussu ASR, Mariúba LAM, Lalwani P, Pereira KDES, Astolphi-Filho S, Orlandi PP, Epiphanio S, Viana KF, Ribeiro MFB, Silva HM, Marinho C R F , Nogueira PA. A hybrid protein containing MSP1a repeats and Omp7, Omp8 and Omp9 epitopes protect immunized BALB/c mice against anaplasmosis [Internet]. Veterinary Research. 2018 ; 49( 1): 1-11 art. 6.Available from: http://dx.doi.org/10.1186/s13567-018-0503-4
    • Vancouver

      Cangussu ASR, Mariúba LAM, Lalwani P, Pereira KDES, Astolphi-Filho S, Orlandi PP, Epiphanio S, Viana KF, Ribeiro MFB, Silva HM, Marinho C R F , Nogueira PA. A hybrid protein containing MSP1a repeats and Omp7, Omp8 and Omp9 epitopes protect immunized BALB/c mice against anaplasmosis [Internet]. Veterinary Research. 2018 ; 49( 1): 1-11 art. 6.Available from: http://dx.doi.org/10.1186/s13567-018-0503-4

    Referências citadas na obra
    Kocan KM, De Fuente J, Alberto A, Meléndez RD, Fuente D, Guglielmone A, Mele RD (2003) Antigens and alternatives for control of Anaplasma marginale infection in cattle. Clin Microbiol Rev 16:698–712
    Kocan KM, De Fuente J, Blouin EF, Coetzee JF, Erwing SA (2010) The natural history of Anaplasma marginale. Vet Parasitol 167:95–107
    Kuttler K (1984) Anaplasma infections in wild and domestic ruminants: a review. J Wildl Dis 20:12–20
    Aubry P, Geale DW (2011) A review of bovine anaplasmosis. Transbound Emerg Dis 58:1–30
    De Vos A, Brock R, Molly J (2006) Tick borne diseases of cattle. In: Australian and New Zealand Standard Diagnostic Procedures. Sub Committee on Animal Health Laboratory Standards pp 1–29
    Woldehiwet Z (2010) The natural history of Anaplasma phagocytophilum. Vet Parasitol 167:108–122
    Palmer GH, Rurangirwa FR, Kocan KM, Brown WC (1999) Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale. Parasitol Today 15:281–286
    Richey EJ, Palmer GH (1990) Bovine anaplasmosis. Compend Contin Educ Pract Vet 12:1661–1668
    Ben Said M, Belkahia H, Alberti A, Zobba R, Bousrih M, Yahiaoui M, Daaloul-Jedidi M, Mamlouk A, Gharbi M, Messadi L (2015) Molecular survey of Anaplasma species in small ruminants reveals the presence of novel strains closely related to A. phagocytophilum in Tunisia. Vector Borne Zoonotic Dis 15:580–590
    Jaswal H, Bal M, Singla L, Gupta K, Brar A (2015) Pathological observations on clinical Anaplasma marginale infection in cattle. J Parasit Dis 39:495–498
    Maharana BR, Tewari AK, Saravanan BC, Sudhakar NR (2016) Important hemoprotozoan diseases of livestock: challenges in current diagnostics and therapeutics: an update. Vet World 9:487–495
    Ducken DR, Brown WC, Alperin DC, Brayton KA, Reif KE, Turse JE, Palmer GH, Noh SM (2015) Subdominant outer membrane antigens in Anaplasma marginale: conservation, antigenicity, and protective capacity using recombinant protein. PLoS One 10:e0129309
    Michelon A, Conceição FR, Binsfeld PC, da Cunha CW, Moreira AN, Argondizzo AP, McIntosh D, Armôa GRG, Campos AS, Farber M, McFadden J, Dellagostin OA (2006) Immunogenicity of Mycobacterium bovis BCG expressing Anaplasma marginale MSP1a antigen. Vaccine 24:6332–6339
    Noh SM, Brayton KA, Brown WC, Norimine J, Munske GR, Davit CM, Palmer GH (2008) Composition of the surface proteome of Anaplasma marginale and its role in protective immunity induced by outer membrane immunization. Infect Immun 76:2219–2226
    Palmer GH, McElwain TF (1994) Molecular basis for vaccine development against anaplasmosis and babesiosis. Vet Parasitol 57:233–253
    Albarrak SM, Brown WC, Noh SM, Reif KE, Scoles GA, Turse JE, Norimine J, Ueti MW, Palmer GH (2012) Subdominant antigens in bacterial vaccines: AM779 is subdominant in the Anaplasma marginale outer membrane vaccine but does not associate with protective immunity. PLoS One 7:e46372
    Dark MJ, Al-khedery B, Barbet AF (2011) Multistrain genome analysis identifies candidate vaccine antigens of Anaplasma marginale. Vaccine 29:4923–4932
    Silvestre BT, Rabelo EML, Versiani AF, Da Fonseca FG, Silveira JAG, Bueno LL, Fujiwara RT, Ribeiro MFB (2014) Evaluation of humoral and cellular immune response of BALB/c mice immunized with a recombinant fragment of MSP1a from Anaplasma marginale using carbon nanotubes as a carrier molecule. Vaccine 32:14–17
    Tebele N, McGuire TC, Palmer GH (1991) Palmer, induction of protective immunity by using Anaplasma marginale initial body membranes. Infect Immun 59:3199–3204
    Crosby FL, Brayton KA, Magunda F, Munderloh UG, Kelley KL, Barbet AF (2015) Reduced infectivity in cattle for an outer membrane protein mutant of Anaplasma marginale. Appl Environ Microbiol 81:2206–2214
    Lopez JE, Siems WF, Palmer GH, Brayton KA, McGuire TC, Norimine J, Brown WC (2005) Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping. Infect Immun 73:8109–8118
    Brayton KA, Kappmeyer LS, Herndon DR, Dark MJ, Tibbals DL, Palmer GH, McGuire TC, Knowles DP (2005) Complete genome sequencing of Anaplasma marginale reveals that the surface is skewed to two superfamilies of outer membrane proteins. Proc Natl Acad Sci U S A 102:844–849
    Palmer GH, Brown W, Noh SM, Brayton KA (2012) Genome-wide screening and identification of antigens for rickettsial vaccine development. FEMS Immunol Med Microbiol 64:115–119
    Herbert K, Seidman D, Oki A, Izac J, Emani S, Oliver LJ, Miller D, Tegels B, Kannagi R, Marconi R, Carlyon J (2017) Anaplasma marginale outer membrane protein A is an adhesin that recognizes sialylated and fucosylated glycans and functionally depends on an essential binding domain. Infect Immun 85:e00968–01016
    Quiroz-castañeda RE, Amaro-Estrada I, Rodríguez-Camarillo SD (2016) Anaplasma marginale: diversity, virulence, and vaccine landscape through a genomics approach. Biomed Res Int 2016:9032085
    Santos PS, Sena AAS, Nascimento R, Araújo TG, Mendes MM, Martins JRS, Mineo TWPJR, Goulart LR (2013) Epitope-based vaccines with the Anaplasma marginale MSP1a functional motif induce a balanced humoral and cellular immune response in mice. PLoS One 8:e60311
    Blas-Machado U, De Fuente J, Blouin EF, Almazán C, Kocan KM, Mysore JV (2007) Experimental infection of C3H/HeJ mice with the NY18 isolate of Anaplasma phagocytophilum. Vet Pathol 44:64–73
    Borjesson DL, Barthold SW (2002) The mouse as a model for investigation of human granulocytic ehrlichiosis: current knowledge and future directions. Comp Med 52:403–413
    Bunnel JE, Trigiani ER, Srinivas SR, Dumler JS (1999) Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system. J Infect Dis 180:546–550
    Yang Q, Ghose P, Ismail N (2013) Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock. Infect Immun 81:1751–1763
    Ortolan LS, Sercundes MK, Barbosa R, Debone D, Murilo O, Hagen SCF, Russo M, D’Imperio Lima MR, Alvarez JM, Amaku M, Marinho CRF, Epiphanio S (2014) Predictive criteria to study the pathogenesis of malaria-associated ALI/ARDS in mice. Mediators Inflamm 2014:872464
    Zhang Q, Wang P, Kim Y, Haste-Andersen P, Beaver J, Bourne PE, Bui HH, Buus S, Frankild S, Greenbaum J, Lund O, Lundegaard C, Nielsen M, Ponomarenko J, Sette A, Zhu Z, Peters B (2008) Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res 36:W513–518
    Zhang Y (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinform 9:40
    Bastos C, Passos P, Facury-Filho E, Rabelo E, De Fuente J, Ribeiro MFB (2010) Protection in the absence of exclusion between two Brazilian isolates of Anaplasma marginale in experimentally infected calves. Vet J 186:374–378
    Chalovich JM, Eisenberg E (2012) Genome-wide screening and identification of antigens for rickettsial vaccine development. FEMS Immunol Med Microbiol 61:115–119
    Wallace J, Hollis L, Reinhardt Coetzee J, Renter LD (2007) Failure to eliminate the Anaplasma marginale carrier state in beef cows following multiple treatments with long-acting injectable oxytetracycline. Bov Pract 41:84–87
    Battilani M, De Arcangeli S, Balboni A, Dondi F (2017) Genetic diversity and molecular epidemiology of Anaplasma. Infect Genet Evol 49:195–211
    Hodzic E, Feng S, Fish D, Leutenegger C, Freet K, Barthold S (2001) Infection of mice with the agent of human granulocytic ehrlichiosis after different routes of inoculation. J Infect Dis 183:1781–1786
    Martink M, Bunnell J, Dumler J (2000) Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J Infect Dis 181:374–378
    MacNamara KC, Racine R, Chatterjee M, Borjesson D, Winslow GM (2009) Diminished hematopoietic activity associated with alterations in innate and adaptive immunity in a mouse model of human monocytic ehrlichiosis. Infect Immun 77:4061–4069
    Scorpio DG, Von Loewenich FD, Göbel H, Bogdan C, Dumler JS (2006) Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury. Clin Vaccine Immunol 13:806–809
    Pagliari C, Quaresma JAS, Kanashiro-Galo L, De Carvalho LV, Vitoria WO, Da Silva WLF, Penny R, Vasconcelos BCB, Da Costa Vasconcelos PF, Duarte MIS (2016) Human kidney damage in fatal dengue hemorrhagic fever results of glomeruli injury mainly induced by IL17. J Clin Virol 75:16–20
    Suttie A (2006) Histopathology of the spleen. Toxicol Pathol 34:466–503
    Elmore S (2006) Enhanced histopathology of the spleen. Toxicol Pathol 34:648–655
    Brown WC, Shkap V, Zhu D, Mcguire TC, Tuo W, McElwain TF, Palmer GH (1998) CD4+ T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect Immun 66:5406–5413
    McGarey DJ, Allred DR (1994) Characterization of hemagglutinating components on the Anaplasma marginale initial body surface and identification of possible adhesins. Infect Immun 62:4587–4593
    Tamekuni K, Kano FS, Ataliba AC, Marana ERM, Venâncio EJ, Vidotto MC, Garcia JL, Headley SA, Vidotto O (2009) Cloning, expression, and characterization of the MSP1a and MSP1b recombinant proteins from PR1 Anaplasma marginale strain, Brazil. Res Vet Sci 86:98–107
    Han S, Norimine J, Palmer GH, Mwang W, Lahmers KK, Brown WC (2008) Rapid deletion of antigen-specific CD4+ T cells following infection represents a strategy of immune evasion and persistence for Anaplasma marginale. J Immunol 181:7759–7769
    Oliveria JB, Madruga CR, Schenk MAM, Kessler RH, Miguita M, Araújo FR (2003) Antigenic characterization of Brazilian isolates of Anaplasma marginale. Mem Inst Oswaldo Cruz 98:395–400
    De Fuente J, Garcia-Garcia JC, Blouin EF, Kocan KM (2003) Characterization of the functional domain of major surface protein 1a involved in adhesion of the rickettsia Anaplasma marginale to host cells. Vet Microbiol 91:265–283
    Cantor G, Pontzer C, Palmer GH (1993) Opsonization of anaplasma marginale mediated by bovine antibody against surface protein MSP-1. Vet Immunol Immunopathol 37:343–350
    Noh SM, Brayton KA, Knowles DP, Agnes JT, Dark MJ, Brown WC, Baszler TV, Palmer GH (2006) Differential expression and sequence conservation of the Anaplasma marginale msp2 gene superfamily outer membrane proteins. Infect Immun 74:3471–3479
    Kawasaki PM, Kano FS, Tamekuni K, Garcia JL, Marana ERM, Vidotto O, Vidotto MC (2007) Immune response of BALB/c mouse immunized with recombinant MSPs proteins of Anaplasma marginale binding to immunostimulant complex (ISCOM). Res Vet Sci 83:347–354

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2020